Exploring the feasibility of PP1-docking motif-mimetic cell-penetrating peptides for modulating prostate carcinogenesis
- Nov 1, 2025
- 1 min read
Our recent paper, “Exploring the feasibility of PP1-docking motif-mimetic cell-penetrating peptides for modulating prostate carcinogenesis”, investigates how PP1-docking motif–mimetic peptides can be used as a novel strategy to modulate prostate cancer progression.
The study bridges molecular mechanisms and translational therapeutic perspectives, highlighting the potential of targeting PP1-regulatory interactions as an innovative approach in prostate cancer biology.
This work contributes to advancing our understanding of PP1 signalling in cancer and explores new opportunities for therapeutic modulation in oncology.
Authored by Renato M. Rodrigues, Juliana Felgueiras, Sarah Jones, Vânia Camilo, Bárbara Matos, Carmen Jerónimo, John Howl, and Margarida Fardilha, this study reflects an international collaboration between research groups in molecular biology and cancer therapeutics.
🔗 Read the accepted version here: https://doi.org/10.1093/jncics/pkaf101
The final version will be available following the journal’s editorial and production process.

Comments